Company / Gross Profit
Illumina, Inc. Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$2.9B
FY2025
5-year range
$2.2B / $3.2B
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
#17 of 100
Health Care
What the data says
Illumina, Inc.'s gross profit of $2.9B is higher than 83% of companies in the Health Care sector (FY2025). Gross Profit has increased for 3 consecutive years, from $2.2B in FY2022 to $2.9B in FY2025.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of +5.4%. Top quartile in the Health Care sector.
Improved from $2.7B to $2.9B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +9.2%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 100This company $2.9B Sector average $1.8B
▼
+57.9% above sector average
Key checks
Key Insights
- Illumina, Inc.'s gross profit has grown for 3 consecutive years.
- 5-year CAGR of +5.4%, indicating consistent growth.
- In FY2025, gross profit increased 0.3% year-over-year.
- Ranks #17 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | +0.3% |
| FY2024 | $2.9B | +4.3% |
| FY2023 | $2.7B | +24.6% |
| FY2022 | $2.2B | -30.2% |
| FY2021 | $3.2B | +43.2% |
| FY2020 | $2.2B | +20.6% |
| FY2019 | $1.8B | +9.6% |
| FY2018 | $1.7B | +7.6% |
| FY2017 | $1.5B | -7.0% |
| FY2016 | $1.7B | +7.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026